A Meta-Analysis of Oxidative Stress Markers in Depression
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
OBJECT: Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls. METHODS: A search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted. RESULTS: 115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers. CONCLUSION: This meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Pooled effect sizes (ES) were calculated according to DerSimonian and Laird for the random effects model because of the diversity of methods, patients’ clinical statuses and treatments [27].”
MethodStang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“Newcastle-Ottawa Scale (NOS) (case control studies or cohort studies) [26].”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
New approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Depression affects millions of people and is the leading global cause of disability according to the World Health Organization [1].”
BackgroundOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 1×
“Oxidative stress is defined as a persistent imbalance between oxidation and anti-oxidation, which leads to the damage of cellular macromolecules [14, 15].”
BackgroundBilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Sarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486
Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458
Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 453
Oxidative & nitrosative stress in depression: Why so much stress?
Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O’Neil, A., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 403
Oxidative stress in anxiety and comorbid disorders
Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365 · cited 1×
“Oxidative stress is defined as a persistent imbalance between oxidation and anti-oxidation, which leads to the damage of cellular macromolecules [14, 15].”
BackgroundMaes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Gastel, A. V., Neels, H., Demedts, P., Wauters, A., & Meltzer, H. Y. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09622.x · Cited by 356
Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322
Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression
Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 308 · cited 2×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundDepression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies
Palta, P., Samuel, L. J., Miller, E. R., & Szanton, S. L. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000009 · Cited by 277 · cited 1×
“comprehensively analysed all oxidative stress markers at once [25].”
BackgroundMaes, M., Vandoolaeghe, E., Neels, H., Demedts, P., Wauters, A., Meltzer, H. Y., Altamura, C., & Desnyder, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00365-4 · Cited by 272
Elevated plasma nitrate levels in depressive states
Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., & Asai, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00164-6 · Cited by 255
Dysregulated relationship of inflammation and oxidative stress in major depression
Rawdin, B. J., Mellon, S. H., Dhabhar, F. S., Epel, E. S., Puterman, E., Su, Y., Burke, H. M., Reus, V. I., Rosser, R., Hamilton, S. P., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.011 · Cited by 255
Maes, M., D'Haese, P. C., Scharpé, S., D'Hondt, P., Cosyns, P., & De Broe, M. E. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90117-1 · Cited by 218
Maes, M., Kubera, M., Leunis, J. ‐., Berk, M., Geffard, M., & Bosmans, E. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01908.x · Cited by 214
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214
Chrapko, W. E., Jurasz, P., Radomski, M. W., Lara, N., Archer, S. L., & Le Mellédo, J.-M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.003 · Cited by 193
Role of antioxidants in generalised anxiety disorder and depression
Gautam, M., Agrawal, M., Gautam, M., Sharma, P., Gautam, A., & Gautam, S. (2012) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.102424 · Cited by 188
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169 · cited 1×
“Recently, many studies have indicated that oxidative stress might play a vital role [2].”
BackgroundNocturnal temperature in affective disorder
Avery, D. H., Wildschiødtz, G., & Rafaelsen, O. J. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90020-9 · Cited by 168
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 160
McLoughlin, I. J., & Hodge, J. S. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb03077.x · Cited by 158
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 154 · cited 1×
“Autoimmune responses against neoepitopes induced by oxidative damage of fatty acid and protein membranes have been reported [10, 11].”
BackgroundLower serum zinc in major depression in relation to changes in serum acute phase proteins.
Maes, M. H. J., Vos, N. D., Demedts, P., Wauters, A., & Neels, H. M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00011-7 · Cited by 152
Szuster‐Ciesielska, A., Słotwińska, M., Stachura, A., Marmurowska-Michałowska, H., Dubas-Ślemp, H., Bojarska-Junak, A. A., & Kandefer‐Szerszeń, M. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.11.012 · Cited by 150
Kotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149 · cited 2×
“Sensitivity analysis of serum TAC in the comparison of before and after the treatment (CBAT) was performed by removing two studies [34, 40], the heterogeneity was no longer significant, and the result remained unchanged.”
BackgroundMethodSerum lipid concentrations in patients with major depressive disorder
Olusi, S. O., & Fido, A. A. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00599-4 · Cited by 148
Rybka, J., Kędziora-Kornatowska, K., Banaś-Leżańska, P., Majsterek, I., Carvalho, L. A., Cattaneo, A., Anacker, C., & Kędziora, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.019 · Cited by 146 · cited 1×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundPomara, N., Bruno, D., Sarreal, A. S., Hernando, R. T., Nierenberg, J. J., Petkova, E., Sidtis, J. J., Wısnıewskı, T., Mehta, P. D., Praticò, D., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11081153 · Cited by 145 · cited 1×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundSelley, M. L. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00135-6 · Cited by 145
Kerling, A., Tegtbur, U., Guetzlaff, E., Kück, M., Borchert, L., Ateş, Z., von Bohlen, A., Frieling, H., Hüper, K., Hartung, D., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.006 · Cited by 127
Amani, R., Saeidi, S., Nazari, Z., & Nematpour, S. (2009) · Biological Trace Element Research · doi:10.1007/s12011-009-8572-x · Cited by 126
The relationship between potency of oxidative stress and severity of depression
Yanık, M., Erel, Ö., & Katı, M. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00090.x · Cited by 126
Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124
Maes, M. H. J., Mihaylova, I., Kubera, M., Leunis, J., & Geffard, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.023 · Cited by 124
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
Praticò, D., Rokach, J., Lawson, J., & FitzGerald, G. A. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.012 · Cited by 120 · cited 1×
“8-F2-isoprostane (8-iso-PGF2α) is another product of LP [18] that is considered to be a marker of LP because of its chemical stability [19].”
BackgroundDepression and oxidative damage to lipids
Yager, S., Forlenza, M. J., & Miller, G. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.03.010 · Cited by 120 · cited 1×
“8-F2-isoprostane (8-iso-PGF2α) is another product of LP [18] that is considered to be a marker of LP because of its chemical stability [19].”
BackgroundIncreased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
Micó, J. A., Rojas-Corrales, M. O., Gibert‐Rahola, J., Parellada, M., Moreno, D. M., Fraguas, D., Graell, M., Gil, J., Irazusta, J., Castro‐Fornieles, J., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-26 · Cited by 118
Brody, S. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01329-x · Cited by 112
Oxidative stress and inflammatory markers are associated with depression and nicotine dependence
Vargas, H. O., Nunes, S. O. V., de Castro, M. R. P., Vargas, M. M., Barbosa, D. S., Bortolasci, C. C., Venugopal, K., Dodd, S., & Berk, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.03.059 · Cited by 110
Amr, M., El-Mogy, A., Shams, T., Vieira, K. F., & Lakhan, S. E. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-31 · Cited by 110
Lehto, S. M., Hintikka, J. J., NISKANEN, L. K., Tolmunen, T., Koivumaa-Honkanen, H. T., Honkalampi, K. M., & Viinamäki, H. T. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.021 · Cited by 106
Increased plasma nitric oxide level associated with suicide attempt in depressive patients
Kim, Y., Paik, J., Lee, S.-W., Yoon, D., Han, C., & Lee, B.-H. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.008 · Cited by 106
Barim, A. Ö., Aydın, S., Çolak, R., Dağ, E., Deniz, O., & Şahin, İ. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.02.020 · Cited by 105
Low plasma vitamin E levels in major depression: diet or disease?
Owen, A. J., Batterham, M. J., Probst, Y., Grenyer, B. F. S., & Tapsell, L. C. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602072 · Cited by 105
Serum uric acid levels and the clinical characteristics of depression
Wen, S., Cheng, M., Wang, H., Yue, J., Wang, H., Li, G., Zheng, L., Zhong, Z., & Peng, F. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.010 · Cited by 104
Neurochemistry of major depression: a study using magnetic resonance spectroscopy
Godlewska, B. R., Near, J., & Cowen, P. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3687-y · Cited by 97 · cited 1×
“Lower glutathione (GSH) levels [12] and a negative relationship between anhedonia severity and occipital GSH levels [13] were found through magnetic resonance spectroscopy (MRS).”
BackgroundAboul-Fotouh, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.027 · Cited by 97
Canan, F., Dikici, S., Kutlucan, A., Celbek, G., Coşkun, H., Güngör, Â., Aydın, Y., & Kocaman, G. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.016 · Cited by 90
Maes, M. H. J., Wauters, A., Neels, H. M., Scharpé, S., Gastel, A. V., D'Hondt, P., Peeters, D., Cosyns, P. R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00106-j · Cited by 89
Maes, M. H. J., Kubera, M., Mihaylova, I., Geffard, M., Gałecki, P., Leunis, J.-C., & Berk, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.039 · Cited by 88
Immune and hormonal activity in adults suffering from depression
Nunes, S. O. V., Reiche, E. M. V., Morimoto, H. K., Matsuo, T., Itano, E. N., Xavier, E. C. D., Yamashita, C., Vieira, V., Menoli, A. V., Silva, S. S., et al. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000500011 · Cited by 88
Prohan, M., Amani, R., Nematpour, S., Jomehzadeh, N., & Haghighizadeh, M. H. (2014) · Redox Report · doi:10.1179/1351000214y.0000000085 · Cited by 87
Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD
Rytilä, P. H., Rehn, T., Ilumets, H., Rouhos, A., Sovijärvi, A. R. A., Myllärniemi, M., & Kinnula, V. L. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-69 · Cited by 86
Bortolasci, C. C., Vargas, H. O., Souza-Nogueira, A., Barbosa, D. S., Moreira, E. G., Nunes, S. O. V., Berk, M., Dodd, S., & Maes, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.018 · Cited by 83
Maes, M. H. J., Vandewoude, M. F. J., Scharpé, S., Clercq, L. D., Stevens, W., Lepoutre, L., & Schotte, C. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90032-n · Cited by 81
Serum trace elements in animal models and human depression. Part I. Zinc
Nowak, G., ba, A. Z., Dudek, D., Krośniak, M., Szymaczek, M., & Schlegel-Zawadzka, M. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199903)14:2<83::aid-hup74>3.0.co;2-6 · Cited by 80
Serum trace elements in animal models and human depression. Part I. Zinc
Nowak, G., ba, A. Z., Dudek, D., Krośniak, M., Szymaczek, M., & Schlegel-Zawadzka, M. (1999) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199903)14:2<119::aid-hup77>3.0.co;2-1 · Cited by 78
Magalhães, P. V. D. S., Jansen, K., Pinheiro, R. T., Colpo, G. D., da Motta, L. L., Klamt, F., da Silva, R. A., & Kapczinski, F. P. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001532 · Cited by 77 · cited 1×
“The protein carbonyl (PC), 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-oxo-7, 8-dihydroguanosine (8-oxoGuo) are the markers of protein, DNA and RNA oxidative damage, respectively [3, 20, 21].”
BackgroundElevated serum copper levels in women with a history of post-partum depression
Crayton, J. W., & Walsh, W. J. (2006) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2006.10.001 · Cited by 76
Maes, M. H. J., Wauters, A., Verkerk, R., Demedts, P., Neels, H., Gastel, A. V., Cosyns, P., Scharpé, S., & Desnyder, R. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00181-c · Cited by 75
Maes, M. H. J., Verkerk, R. M., Vandoolaeghe, E., Hunsel, F. V., Neels, H. M., Wauters, A., Demedts, P., & Scharpé, S. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03033069 · Cited by 74
Jorgensen, A., Krogh, J., Miskowiak, K., Bolwig, T. G., Kessing, L. V., Fink-Jensen, A., Nordentoft, M., Henriksen, T., Weimann, A., Poulsen, H. E., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.011 · Cited by 74
Lehto, S. M., Niskanen, L., Tolmunen, T., Hintikka, J., Viinamäki, H., Heiskanen, T., Honkalampi, K., Kokkonen, M., & Koivumaa‐Honkanen, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02079.x · Cited by 72
Lapidus, K. A. B., Gabbay, V., Mao, X., Johnson, A., Murrough, J. W., Mathew, S. J., & Shungu, D. C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.056 · Cited by 72
High serum uric acid level in adolescent depressive patients
Tao, R., & Li, H. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.031 · Cited by 69
Hunsel, F. V., Wauters, A., Vandoolaeghe, E., Neels, H. M., Demedts, P., & Maes, M. H. J. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)03010-7 · Cited by 67
Sevinçok, L., KARUL, A. B., & Dereboy, F. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600110 · Cited by 66
Vargas, H. O., Nunes, S. O. V., Barbosa, D. S., Vargas, M. M., Cestari, A., Dodd, S., Venugopal, K., Maes, M. H. J., & Berk, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.033 · Cited by 66
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Orzechowska, A., Chamielec, M., Bartosz, G., & Kowalczyk, E. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.01.018 · Cited by 66
Huang, T., Wu, S., Chiang, Y.-S., & Chen, J. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00071-4 · Cited by 65
Self-citationSarandöl, A., Sarandöl, E., Eker, S. S., Karaagac, E. U., Hizli, B., Dirican, M., & Kırlı, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.012 · Cited by 64
Zieba, A., Kata, R., Dudek, D., Schlegel-Zawadzka, M., & Nowak, G. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.231 · Cited by 63
Chaudhari, K., Khanzode, S. D., Khanzode, S. D., Dakhale, G. N., Saoji, A., & Sarode, S. C. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0016-z · Cited by 61
Wiener, C. D., Rassier, G. T., Kaster, M. P., Jansen, K., Pinheiro, R. T., Klamt, F., Magalhães, P. V. D. S., Kapczinski, F. P., Ghisleni, G., & da Silva, R. A. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.05.006 · Cited by 61
Karlović, D., Buljan, D., Martinac, M., & Marčinko, D. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.3.431 · Cited by 60
Decreased NOS1 Expression in the Anterior Cingulate Cortex in Depression
Gao, S., Qi, X., Zhao, J., Balesar, R. A., Bao, A., & Swaab, D. F. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs285 · Cited by 60 · cited 1×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundHocaoğlu, Ç., Kural, B. V., Aliyazıcıoğlu, R., Değer, O., & CENGİZ, S. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9323-9 · Cited by 56
Maes, M. H. J., Meester, I. D., Verkerk, R. M., Medts, P. D., Wauters, A., Vanhoof, G., Vandoolaeghe, E., Neels, H. M., & Scharpé, S. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00040-6 · Cited by 55
Moreno-Fernández, A. M., Cordero, M. D., Garrido-Maraver, J., Alcocer-Gómez, E., Casas-Barquero, N., Carmona-López, M. I., Sánchez-Alcázar, J. A., & de Miguel, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.002 · Cited by 54 · cited 1×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundLevels of copper and zinc in depression.
Narang, R. L., Gupta, K., Narang, A. P. S., & Singh, R. P. (1991) · PubMed · Cited by 52
Characterization of the Lipid Profile in Dementia and Depression in the Elderly
Dimopoulos, N. P., Piperi, C., Salonicioti, A., Psarra, V., Mitsonis, C., Liappas, I., Lea, R. W., & Kalofoutis, A. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988707301867 · Cited by 50
Maes, M. H. J., Mihaylova, I., Kubera, M., & Leunis, J. (2008) · PubMed · Cited by 46
Oxidative stress and brain glutamate-mediated excitability in depressed patients
Salustri, C., Squitti, R., Zappasodi, F., Ventriglia, M., Bevacqua, M. G., Fontana, M., & Tecchio, F. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.05.012 · Cited by 42
Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity.
Razavi, À. E., Ani, M., Pourfarzam, M., & Naderi, G. A. (2012) · Europe PMC (PubMed Central) · Cited by 42
Major depression induces oxidative stress and platelet hyperaggregability
do Carmo, M. B. O. O., Mendes‐Ribeiro, A. C., Matsuura, C., Pinto, V. L. M., Mury, W. V., Pinto, N. O., Moss, M. B., Ferraz, M. R., & Brunini, T. M. C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.12.009 · Cited by 40
Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women
Milaneschi, Y., Cesari, M., Simonsick, E. M., Vogelzangs, N., Kanaya, A. M., Yaffe, K. S., Patrignani, P., Metti, A. L., Kritchevsky, S. B., Pahor, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065406 · Cited by 40 · cited 1×
“Some studies have demonstrated that depressed patients’ oxidative product levels in their peripheral blood [3, 4], red blood cells (RBC) [4], mononuclear cells [5], urine [6], cerebrospinal fluid [7] and postmortem brains [8] were abnormal.”
BackgroundPinto, V. L. M., Fontoura, P., Brunini, T. M. C., Oliveira, M. B. L., Moss, M. B., Siqueira, M. A. D. S., Ferraz, M. R., & Mendes‐Ribeiro, A. C. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.008 · Cited by 38
Possible role of adrenomedullin and nitric oxide in major depression
Akpınar, A., Yaman, G. B., Demirdaş, A., & Önal, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.003 · Cited by 35
Ebesunun, M., Eruvulobi, H., Olagunju, T. O., & Owoeye, O. A. (2012) · African Journal of Psychiatry · doi:10.4314/ajpsy.v15i1.3 · Cited by 35
Lower serum albumin levels in patients with mood disorders.
Huang, T. (2002) · PubMed · Cited by 34
Late-life depression symptom profiles are differentially associated with immunometabolic functioning
Vogelzangs, N., Comijs, H. C., Oude Voshaar, R. C., Stek, M. L., & Penninx, B. W. J. H. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.05.004 · Cited by 32
Yapışlar, H., Aydoğan, S., & Özüm, Ü. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.620127 · Cited by 29
Uzbekov, M. G., Misionzhnik, E. Y., Maximova, N., & Вертоградова, О. П. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.749 · Cited by 29
Russo, A. J. (2010) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s5044 · Cited by 25
Lawlor, D. A., Day, I. N. M., Gaunt, T. R., Hinks, L. J., Timpson, N. J., Ebrahim, S. B. J., & Smith, G. D. (2006) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.049247 · Cited by 23 · cited 2×
“Lawlor et al (2007) reported the R allele of PON1Q192R was associated with depression [147].”
BackgroundIkenouchi, A., Yoshimura, R., Kishi, T., Umene‐Nakano, W., Hori, H., Hayashi, K., Katsuki, A., Ueda, N., Iwata, N., & Nakamura, J. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1239 · Cited by 21
Canpolat, S., Kırpınar, İ., Deveci, E., Aksoy, H., Bayraktutan, Z., Eren, İ., Demir, R., Selek, S., & Aydın, N. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/624395 · Cited by 18
Lower Total Serum Protein, Albumin and Zinc in Depression in an Iranian Population
Salimi, S., Kianpoor, M., Abassi, M. R., Abdani, M., & Moghadam, E. S. (2008) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2008.587.590 · Cited by 14
Ghodake, S. R., Suryakar, A. N., Kulhalli, P. M., Ramch, Padalkar, R. K., & Shaikh, A. K. (2012) · Current Neurobiology · Cited by 14
DEFENSE MECHANISMS IN CHINESE PATIENTS WITH COMORBID ANXIETY AND DEPRESSION
Yuan, Y., Zhang, X. B., & Wu, A. Q. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200204000-00010 · Cited by 13
Serum lipids : new biological markers in depression ?
Khalid, A., Lal, N., Jk, T., Dalal, P., Asthana, O. P., Srivastava, J., & Akhtar, A. (1998) · Europe PMC (PubMed Central) · Cited by 13
Bal, N., Acar, Ş. T., Yazıcı, A. C., & Tamer, L. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2012250302 · Cited by 12 · cited 1×
“As a product of LP, abnormal malondialdehyde (MDA) levels in depression have been reported [17].”
BackgroundSelek, S., Dalkiliç, A., Kaya, M., SAVAS, H. A., Bez, Y., Çelık, H., Erel, Ö., Kaptanoğlu, B., & Herken, H. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.11.001 · Cited by 10 · cited 1×
“Sensitivity analysis of serum TAC in the comparison of before and after the treatment (CBAT) was performed by removing two studies [34, 40], the heterogeneity was no longer significant, and the result remained unchanged.”
MethodThe Associations between High-Density Lipoprotein mean Particle Size and its Fatty Acid Composition
Razavi, À. E., Pourfarzam, M., Ani, M., & Naderi, G. A. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.12.115 · Cited by 9
Does the lower nitric oxide level cause cardiovascular changes in major depressed women?
Arslan, A., & UZUN, M. (2008) · PubMed · Cited by 8
EFFECTS OF MODERATE EXERCISE ON MILD DEPRESSIVE MOOD, ANTIOXIDANTS AND LIPID PEROXIDATION
Fadıllıoğlu, E., Kaya, B., Uz, E., Emre, M. H., & Ünal, S. (2021) · Psychiatry and Clinical Psychopharmacology · Cited by 6
We, H. (2003) · Sichuan Mental Health · Cited by 6
Mingzhi, X. (2000) · Chin J Psychiatry · Cited by 5
Wang, C., 张中兴, 王长虹, 谢光荣, 周伟强, 汤艳清, & 刘光亚 (2005) · Zhonghua xingwei yixue yu naokexue zazhi · doi:10.3760/cma.j.issn.1005-8559.2005.09.011 · Cited by 1
Chen, Z. (1995) · Xinxiang yixueyuan xuebao · Cited by 1
The Study of Correlation Between Depression and Metabolic Syndrome in Women
Guan, C. (2011) · Guide of China Medicine · Cited by 1
Existence of lipid metabolism dysfunction in patients with endogenous depression
Liu, L. (2006) · Laboratory Medicine · Cited by 1
Research works printed but not linked: 32
- N Bal, 2012, Altered Levels of Malondialdehyde and Vitamin E in Major Depressive Disorder and Generalized Anxiety Disorder, Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 25, 206
- ZP Qian, 2012, A study of correlation between serum zinc and lithium levels of depressed patients, Medical Laboratory Science and Clinics, 23, 64
- Y Chen, 2010, A study of serum IL-1β, IL-6 and blood SOD levels in patients of depression, Neural Injury and Functional Reconstruction January, 5, 74
- JM Hu, 1996, Analysis of superoxide dismutase activity of red blood cell in patients with schizophrenia and depression, Chinese Journal of Nervous and Mental Diseases, 22, 86
- ZZ Huang, 1999, Study on lipid peroxide, superoxide dismutase and glutathione peroxidase in patients with affective disorder, Chin J Psychiatry, 32, 191
- J He, 2000, The clinical study of antioxidative capacity in psychiatry patients, Chinese Journal of Behavio ral Medical Science, 9, 139
- XH Zhang, 1997, Changes of plasma SOD activity and MDA level in patients with depression and anxiety, Journal of Convalescen and Rehabilitation, 12, 157
- SL Wen, 2013, Analysis on serum levels of non-enzyme antioxidants and intelligence quotient in patients with recurrent depression, Chin Prev Med, 14, 579
- MF Chen, 2010, Analysis on serum levels of uric acid in patients with depression, Chin J Prev Chron Dis, 18, 302
- MF Chen, 2012, Plasma Non-enzyme Antioxidants Levels in the Depressive Patients with Attempted Suicide, Chin J Prev Chron Dis, 20, 529
- J Lu, 2010, The effect of escitalopram on serum glucose and lipids, Medical Journal of Chinese People’s Health, 22, 2242
- YG Yuan, 2002, Serum lipid concentrations in patients with comorbid anxiety and depression, Chin J Nerv Ment Dis, 28, 33
- YG Yuan, 2006, A study of serum lipid concentrations and apolipoprotein E genotype among patients with senile depression and alzhemier disease, Chinese General Practice, 9, 106
- YG Yuan, 2003, The relation ship between plasma monoamine neurotransmitters and serum lipid concentrations in depressive patients, J Clin Psychol Med, 13, 67
- XB Huang, 2003, Serum lipid and catecholamin concentrations in patients with anxiety and depression, J Clin Psychol Med, 13, 94
- MD Wu, 2004, A study of serum lipid concentrations in 536 patients of psychiatric disorders, Journal of Sichuan Continuing Education College of MS, 23, 175
- XH Wang, 2014, A study of physical function, serum lipids and cytokines in 48 uygur elderly patients with depression, Xinjiang Medical Journal, 44, 61
- YC Lv, 2011, Analysis of suicidal behavior and detection of biological parameter in patients with depressive disorder, Journal of Medical Forum, 32, 7
- GH Wang, 2003, The levels of the cholesterol, triglyceride, lipoprotein, apolipoprotein in young depression patients, MedicaI JournaI of Wuhan University, 24, 174
- RP Che, 2014, The study on lipid metabolism in 86 patients with first episode depression, Journal of Practical Medical Techniques, 21, 664
- WJ Zhang, 2012, The clinical study of serum thyroid hormone and lipid levels in patients with first episode depression, Chin J Lab Diagn, 16, 712
- QC Xia, 2009, Study of metabolism of glucose and lipid in patients of first-episode depressioon, J Clin Psychiatry, 19, 241
- CY Li, 2011, The comparative study on serum glucose and lipids in patients with first episode depression, Medical Journal of ChinesePeople’s Health, 23, 1355
- WL He, 2013, Research on lipid metabolism of the first-episode patients with depression, World Health Digest Medical Periodieal, 10, 413
- YM Jiao, 2006, Fasting blood glucose and serum lipid level in patients with major depression and their relations to psychopathology, Shanghai Archives of Psychiatry, 18, 266
- FX Wu, 1998, Depression and hemorheology, J Clin Psychol Med, 8, 341
- HY Yu, 1997, The mearsure of trace element in red blood cell and serum of depressed patients, Hebei Mental Health, 10, 10
- MD Fernández-González, 1998, Trace elements in serum of psychiatric outpatients, Química Clínica, 17, 208
- XR Chang, 2001, The mearsure of serum 14 kinds of trace element in patients of depression, Chinese Journal of Behavioral Medical Science, 10, 589
- XQ Guo, 2011, A study of serum ten kinds of trace element level changes in depressed patients, China Health Monthly, 1, 136
- GF Wu, 2012, A study of correlation between cytokine, serum zinc level, thyroid hormone and depression, The Public Health, 6, 61
- XW Xu, 2010, The mearsure of MAO, MDA, hs-CRP levels and their clinical meaning in patients of depression, Medical Innovation of Chin, 7, 175
Cited by
Diet and depression: Exploring the biological mechanisms of action
Marx, W., Lane, M., Hockey, M., Aslam, H., Berk, M., Walder, K., Borsini, A., Firth, J., Pariante, C. M., Berding, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00925-x · Cited by 685
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Studies have reported higher levels of oxidative stress byproducts and lower levels of antioxidant enzymes (103).”
BackgroundMolecular pathways of major depressive disorder converge on the synapse
Fries, G. R., Saldana, V. A., Finnstein, J., & Rein, T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01806-1 · Cited by 504
Nutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469
“Furthermore, a recent meta-analysis of 115 studies reported lower antioxidant capacity in depressed patients during acute episodes((28)).”
The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1016-x · Cited by 306
Metadata
- Authors
- Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y.
- Affiliations
- Jinan University (CN)
- Corresponding author
- Jia, Yanbin
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0138904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596519
- OpenAlex
- W2105160377
- Cited by
- 485
- References
- 125
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 42 · 2023: 54 · 2022: 51 · 2021: 78 · 2020: 63 · 2019: 39 · 2018: 43 · 2017: 27 · 2016: 15
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jinan University
- Department of Education of Guangdong Province
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- depression, oxidative stress, total antioxidant capacity, antioxidants, paraoxonase, uric acid, malondialdehyde, 8-isoprostane, free radicals, oxidative damage, antidepressant treatment, acute depressive episode, antioxidant supplementation
- MeSH terms
- Albumins, Antidepressive Agents, Antioxidants, Ascorbic Acid, Cross-Sectional Studies, Depression, Depressive Disorder, Humans, Lipoproteins, HDL, Malondialdehyde, Uric Acid, Lipid Peroxidation, Biomarkers, Case-Control Studies, Oxidative Stress, F2-Isoprostanes, Aryldialkylphosphatase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.